Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
Favipiravir and baloxavir acid were evaluated for their antiviral activity against SARS-CoV-2 before the trial. One reason for the lack of virological effect and clinical benefits may be due to insufficient concentrations of these drugs, authors say.
